[Translation] Bioequivalence of lacidipine tablets in open, randomized, single-dose, three-cycle, three-sequence, partially repeated cross-fasting state and open, randomized, single-dose, double-cycle, double-cross fed state in healthy subjects sex test
主要目的:比较空腹及餐后给药条件下,哈药集团三精明水药业有限公司提供的拉西地平片(4 mg/片)与GLAXOSMITHKLINE,S.A持证的拉西地平片(4 mg/片,商品名:Lacipil®)在健康成年人群中吸收程度和速度的差异,评价其生物等效性。 次要目的:评价空腹及餐后给药条件下,哈药集团三精明水药业有限公司提供的拉西地平片(4 mg/片)与GLAXOSMITHKLINE,S.A持证的拉西地平片(4 mg/片,商品名:Lacipil®)的安全性。
[Translation] Main purpose: To compare the Lacidipine Tablets (4 mg/tablet) provided by Harbin Pharmaceutical Group Sanjingmingshui Pharmaceutical Co., Ltd. and the Lacidipine Tablets (4 mg/ Tablets, trade name: Lacipil®) in the healthy adult population in the degree and speed of absorption, to evaluate its bioequivalence. Secondary purpose: To evaluate the lacidipine tablets (4 mg/tablet) provided by Harbin Pharmaceutical Group Sanjingmingshui Pharmaceutical Co., Ltd. and the lacidipine tablets (4 mg / tablet, trade name: Lacipil®).